Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
NPC Blog
NPC Blog
2010 Archives
2009 Archives
2008 Archives
2007 Archives
2006 Archives
Search Archives
Archives
  • December 2012 (3)
  • November 2012 (1)
  • October 2012 (1)
  • May 2012 (1)
  • December 2011 (1)
  • November 2011 (3)
  • October 2011 (4)
  • September 2011 (4)
  • August 2011 (6)
  • July 2011 (13)
  • June 2011 (8)
  • May 2011 (10)
  • April 2011 (14)
  • March 2011 (6)
  • February 2011 (2)
  • February 2010 (4)
  • January 2010 (1)
  • December 2009 (1)
  • November 2009 (1)
  • October 2009 (1)
  • September 2009 (2)
  • July 2009 (1)
  • April 2009 (1)
  • March 2009 (1)
  • February 2009 (1)
  • December 2008 (1)
  • October 2008 (1)
  • September 2008 (1)
  • August 2008 (2)
  • July 2008 (2)
  • June 2008 (4)
  • May 2008 (1)
  • April 2008 (1)
  • March 2008 (4)
  • February 2008 (1)
  • April 2007 (1)
  • December 2006 (1)
  • October 2006 (1)
  • September 2006 (1)
  • July 2006 (2)
  • June 2006 (3)
  •  

    Subscribe in a reader

    E-Alerts
    Signup to receive news and announcements from Nutra Pharma:
    First Name:
    Last Name:
    Email:
     
    Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

    NPC Blog

    Archive for October, 2011

    Nutra Pharma’s CEO, Rik J. Deitsch was interviewed for the website, Wall Street Reporter – providing updates on the Company’s activities and goals. October 28, 2011 — Coral Springs, Florida — Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, [...]

    Read Full Post »

     

    Nutra Pharma has been issued a patent by the U.S. Patent and Trademark Office that protects their therapy for Multiple Sclerosis (MS). The patent is entitled, “Modified anticholinergic neurotoxins as modulators of the autoimmune reaction.” October 19, 2011 — Coral Springs, Florida — Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments [...]

    Read Full Post »

     

    A new research study reported in the Journal of Pain shows that acute and chronic lower back pain have distinct components. Thanks to these findings, doctors may become better able to predict which cases of acute pain will turn into chronic pain (2011;12:792-800). [Pain Medicine News, September 2011, volume 9:09] Acute pain is defined as [...]

    Read Full Post »

     

    Nutra Pharma announced today that DNAA, Inc will serve as their Distributor in Panama for its Nyloxin-branded pain relievers. Coral Springs, FL. – October 14, 2011 – Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain announced today that it [...]

    Read Full Post »

     

     
    Quick Nav
    Nyloxin // Chronic Pain Relief
    Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
     

     

     
    Recent News
     
    March 14, 2017
    Nutra Pharma CEO Rik Deitsch Interviewed by Stockguru.com


    February 22, 2017
    Global Small Caps Initiates Coverage on Nutra Pharma


    February 15, 2017
    Nutra Pharma and Nyloxin Featured on NBC News-Miami


     
     
     
    Announcements
    Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
     
     
    Facebook   Twitter
     
    NPC
    Privacy Policy Code of Ethics